Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
Clinical trial NCT04144140 · TERMINATED
Trial details
- NCT number
- NCT04144140
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2022-07-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.